Scarica l'app Stockscreener
9.84
1.89%
-0.19
Dopo l'orario di chiusura:
9.69
-0.15
-1.52%
Nurix Therapeutics Inc Borsa (NRIX) Ultime notizie
Will Nurix Therapeutics Inc. stock outperform tech sector in 2025July 2025 News Drivers & Fast Gain Stock Tips - Trung tâm Dự báo KTTV quốc gia
Precision Oncology Approaches Drive $312B Market Transformation - WV News
Can Nurix Therapeutics Inc. stock hit record highs againIPO Watch & Long-Term Capital Growth Strategies - newser.com
Nurix Therapeutics (NASDAQ:NRIX) Stock Price Up 12.4%Should You Buy? - MarketBeat
HC Wainwright Issues Pessimistic Estimate for NRIX Earnings - MarketBeat
Is Nurix Therapeutics Inc a good long term investmentEarnings Growth Patterns & Affordable Growth Investments - earlytimes.in
How to manage a losing position in Nurix Therapeutics Inc.Quarterly Profit Report & AI Based Buy and Sell Signals - newser.com
Is Nurix Therapeutics Inc. forming a reversal patternBond Market & AI Based Buy/Sell Signal Reports - newser.com
Earnings visualization tools for Nurix Therapeutics Inc.Earnings Overview Summary & Capital Protection Trade Alerts - newser.com
Nurix Therapeutics (NASDAQ:NRIX) Price Target Lowered to $15.00 at Morgan Stanley - MarketBeat
NRIX: Morgan Stanley Maintains Rating, Lowers Price Target to $1 - GuruFocus
NRIX: HC Wainwright & Co. Maintains Rating but Lowers Price Targ - GuruFocus
HC Wainwright & Co. Maintains Nurix Therapeutics (NRIX) Buy Recommendation - Nasdaq
Using data models to predict Nurix Therapeutics Inc. stock movement2025 Price Action Summary & Consistent Profit Focused Trading Strategies - newser.com
What technical charts say about Nurix Therapeutics Inc. stockPortfolio Gains Report & Verified Stock Trade Ideas - newser.com
Nurix Therapeutics Reports Increased Losses Amid R&D Expansion - TipRanks
Nurix Therapeutics (NASDAQ:NRIX) Shares Down 4.4%Should You Sell? - MarketBeat
Will Nurix Therapeutics Inc. stock recover faster than peersTreasury Yields & AI Powered Market Entry Strategies - newser.com
Applying chart zones and confluence areas to Nurix Therapeutics Inc.2025 Fundamental Recap & Consistent Profit Alerts - newser.com
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year - simplywall.st
Nurix Therapeutics (NRIX): Losses Worsen 21.7% Annually, Reinforcing Profitability Concerns Despite Growth Narrative - Yahoo Finance
Nurix Therapeutics (NASDAQ:NRIX) Shares Gap Down Following Weak Earnings - MarketBeat
Nurix: Bexobrutideg Advancement Presses Forward With H2 2025 Milestones (NASDAQ:NRIX) - Seeking Alpha
Nurix Therapeutics (NASDAQ:NRIX) Announces Quarterly Earnings Results - MarketBeat
Wall Street Zen Downgrades Nurix Therapeutics (NASDAQ:NRIX) to Strong Sell - MarketBeat
Nurix Therapeutics (NASDAQ:NRIX) Trading 8.7% HigherStill a Buy? - MarketBeat
Oppenheimer Maintains Nurix Therapeutics (NRIX) Outperform Recommendation - Nasdaq
What analysts say about Nurix Therapeutics Inc stockTake Profit Strategies & Low Cost Portfolio Ideas - earlytimes.in
Nurix Therapeutics (NRIX) Stock Falls After Q3 Earnings Miss - GuruFocus
Using portfolio simulators with Nurix Therapeutics Inc. includedOil Prices & Accurate Technical Buy Alerts - newser.com
Is Nurix Therapeutics Inc. showing signs of accumulationJuly 2025 Breakouts & Long Hold Capital Preservation Plans - newser.com
Nurix Therapeutics (NRIX) Analyst Rating Update: Piper Sandler L - GuruFocus
Detecting price anomalies in Nurix Therapeutics Inc. with AIJuly 2025 Update & Short-Term High Return Ideas - newser.com
Nurix Therapeutics (NRIX) Price Target Lowered by Oppenheimer | - GuruFocus
Nurix Therapeutics (NASDAQ:NRIX) Receives Sell (D-) Rating from Weiss Ratings - MarketBeat
Nurix Therapeutics Posts Downbeat Q3 Results, Joins Orthopediatrics, Levi Strauss And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
Nurix Therapeutics (NRIX) Reports Wider Q3 Earnings Miss - GuruFocus
Levi Strauss, USANA Health Sciences And 3 Stocks To Watch Heading Into Friday - Benzinga
Nurix Therapeutics Inc reports results for the quarter ended August 31Earnings Summary - TradingView
Nurix Therapeutics Reports Third Quarter 2025 Financial Results And Provides A Corporate Update - TradingView
Nurix Therapeutics Doubles Down On Pivotal Trials Despite Losses - Finimize
Nurix Therapeutics, Inc. (NRIX) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance
Nurix Therapeutics Inc Reports Q3 2025 Earnings: EPS of ($1.03) Misses Estimates, Revenue at $7.9 Million Falls Short - GuruFocus
NRIX Q3 Revenue Falls Short; Future Research Endeavors Outlined - GuruFocus
Nurix Therapeutics shares tumble 9% on wider-than-expected Q3 loss, revenue miss - Investing.com Nigeria
Nurix Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update - The Manila Times
Nurix Therapeutics' Q3 revenue falls 37%, net loss widens - MarketScreener
Earnings Flash (NRIX) Nurix Therapeutics, Inc. Reports Q3 Revenue $7.9M, vs. FactSet Est of $16.0M - MarketScreener
How Nurix Therapeutics Inc. stock performs in weak economyQuarterly Investment Review & High Conviction Investment Ideas - newser.com
Smart tools for monitoring Nurix Therapeutics Inc.’s price action2025 Sector Review & Technical Confirmation Trade Alerts - newser.com
1.84%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):